Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Clinical Pharmacokinetics|May 4, 2026
Effect of Enzalutamide on Morphine Exposure in Patients with Prostate CancerCatharina J P Op 't Hoog, Niven Mehra, Benthe van der Weij, et al.
BJU International|April 4, 2017
Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics - a decision analytical modelSiebren Dijkstra, Tim M Govers, Rianne J Hendriks, et al.
Clinical Pharmacokinetics|April 24, 2016
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and EnzalutamideGuillemette E Benoist, Rianne J Hendriks, Peter F A Mulders, et al.
British Journal of Clinical Pharmacology|November 23, 2025
Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancerCatharina J P Op 't Hoog, Niven Mehra, Anouk van Kleef, et al.
The Journal of Urology|November 12, 2013
Prostate cancer biomarker profiles in urinary sediments and exosomesSiebren Dijkstra, Ingrid L Birker, Frank P Smit, et al.
Investigative Radiology|February 2, 2012
Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated seriesDiederik M Somford, Thomas Hambrock, Christina A Hulsbergen-van de Kaa, et al.
Cancers|December 17, 2020
Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate CancerMinke Smits, Kamer Ekici, Samhita Pamidimarri Naga, et al.
European Urology Focus|November 11, 2020
A Systematic Review of the Use of Social Media for Dissemination of Clinical Practice GuidelinesNikita R Bhatt, Stefan W Czarniecki, Hendrick Borgmann, et al.
Investigative Radiology|January 13, 2010
Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapyDerya Yakar, Thomas Hambrock, Henkjan Huisman, et al.
The Prostate|August 31, 2017
A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detectionRianne J Hendriks, Marloes M G van der Leest, Siebren Dijkstra, et al.
Pageof 14